TriLink BioTechnologies has launched its Analytical Sciences Center of Excellence (ASCE) hub. Expanding its comprehensive suite of analytical testing capabilities, this new center of excellence will minimize the delays and unexpected costs typically associated with outsourced testing to multiple laboratories. This new center of excellence will serve as the hub for all analytical innovation and the Quality Control laboratories across the organization's manufacturing network.

Located within Maravai LifeSciences's Pacific Center Boulevard facility in San Diego's Sorrento Valley, the ASCE will operate out of a 4,000-square-foot lab equipped with advanced instrumentation and support developers as they advance their drugs - starting with plasmid DNA and continuing through mRNA manufacturing and release. Leaning on decades of technical expertise, TriLink continues to lead the market with mRNA specific analytical services, having developed and qualified 10 types of unique methods for the characterization of mRNA covering 40 various constructs. With this expansion, the center of excellence builds upon the organization's comprehensive method development for construct-specific assays with new instrumentation to improve NMR, NGS, and LNP characterization.

The center of excellence will also be responsible for developing cutting-edge analytical methodologies, including mRNA fingerprinting and sequencing. In addition to the ASCE's suite of analytical services, TriLink has a robust ®? mRNA capping portfolio, advanced scale-up capabilities, and unrivaled expertise in mRNA, oligonucleotide, and plasmid production.

Leveraging more than 25 years of experience, TriLink serves companies dedicated to advancing therapeutics, vaccines, and diagnostics by delivering exceptional Contract Development and Manufacturing Organization (CDMO) services.